190 related articles for article (PubMed ID: 37108278)
1. Assessing the Role of MicroRNAs in Predicting Breast Cancer Recurrence-A Systematic Review.
Bouz Mkabaah L; Davey MG; Lennon JC; Bouz G; Miller N; Kerin MJ
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108278
[TBL] [Abstract][Full Text] [Related]
2. Panels of circulating microRNAs as potential diagnostic biomarkers for breast cancer: a systematic review and meta-analysis.
Nguyen THN; Nguyen TTN; Nguyen TTM; Nguyen LHM; Huynh LH; Phan HN; Nguyen HT
Breast Cancer Res Treat; 2022 Nov; 196(1):1-15. PubMed ID: 36085533
[TBL] [Abstract][Full Text] [Related]
3. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S
Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526
[TBL] [Abstract][Full Text] [Related]
4. Identification of a circulating microRNA signature to distinguish recurrence in breast cancer patients.
Huo D; Clayton WM; Yoshimatsu TF; Chen J; Olopade OI
Oncotarget; 2016 Aug; 7(34):55231-55248. PubMed ID: 27409424
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of exosomal miRNAs between breast cancer patients with and without recurrence.
Sueta A; Yamamoto Y; Tomiguchi M; Takeshita T; Yamamoto-Ibusuki M; Iwase H
Oncotarget; 2017 Sep; 8(41):69934-69944. PubMed ID: 29050253
[TBL] [Abstract][Full Text] [Related]
6. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
[TBL] [Abstract][Full Text] [Related]
7. Plasma Circulating Mirnas Profiling for Identification of Potential Breast Cancer Early Detection Biomarkers.
Jusoh AR; Mohan SV; Lu Ping T; Tengku Din TADAAB; Haron J; Romli RC; Jaafar H; Nafi SN; Tuan Salwani TI; Yahya MM
Asian Pac J Cancer Prev; 2021 May; 22(5):1375-1381. PubMed ID: 34048164
[TBL] [Abstract][Full Text] [Related]
8. Circulating microRNAs can predict chemotherapy-induced toxicities in patients being treated for primary breast cancer.
Davey MG; Abbas R; Kerin EP; Casey MC; McGuire A; Waldron RM; Heneghan HM; Newell J; McDermott AM; Keane MM; Lowery AJ; Miller N; Kerin MJ
Breast Cancer Res Treat; 2023 Nov; 202(1):73-81. PubMed ID: 37540289
[TBL] [Abstract][Full Text] [Related]
9. A two-miRNA signature of upregulated miR-185-5p and miR-362-5p as a blood biomarker for breast cancer.
Zhang K; Wang YY; Xu Y; Zhang L; Zhu J; Si PC; Wang YW; Ma R
Pathol Res Pract; 2021 Jun; 222():153458. PubMed ID: 33962174
[TBL] [Abstract][Full Text] [Related]
10. High expression levels of miR-21 and miR-210 predict unfavorable survival in breast cancer: a systemic review and meta-analysis.
Tang Y; Zhou X; Ji J; Chen L; Cao J; Luo J; Zhang S
Int J Biol Markers; 2015 Nov; 30(4):e347-58. PubMed ID: 26349663
[TBL] [Abstract][Full Text] [Related]
11. Plasma-based microRNA signatures in early diagnosis of breast cancer.
Li X; Zou W; Wang Y; Liao Z; Li L; Zhai Y; Zhang L; Gu S; Zhao X
Mol Genet Genomic Med; 2020 May; 8(5):e1092. PubMed ID: 32124558
[TBL] [Abstract][Full Text] [Related]
12. Systematic review of circulating MICRORNAS as biomarkers of cervical carcinogenesis.
Nascimento NPG; Gally TB; Borges GF; Campos LCG; Kaneto CM
BMC Cancer; 2022 Aug; 22(1):862. PubMed ID: 35933332
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the Role of Circulating MicroRNAs in Predicting Long-Term Survival Outcomes in Breast Cancer: A Prospective, Multicenter Clinical Trial.
Davey MG; McGuire A; Casey MC; Waldron RM; Paganga M; Holian E; Newell J; Heneghan HM; McDermott AM; Keane MM; Lowery AJ; Miller N; Kerin MJ
J Am Coll Surg; 2023 Feb; 236(2):317-327. PubMed ID: 36648259
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
[TBL] [Abstract][Full Text] [Related]
15. Tumor microRNA expression profiling identifies circulating microRNAs for early breast cancer detection.
Matamala N; Vargas MT; González-Cámpora R; Miñambres R; Arias JI; Menéndez P; Andrés-León E; Gómez-López G; Yanowsky K; Calvete-Candenas J; Inglada-Pérez L; Martínez-Delgado B; Benítez J
Clin Chem; 2015 Aug; 61(8):1098-106. PubMed ID: 26056355
[TBL] [Abstract][Full Text] [Related]
16. Meta-microRNA Biomarker Signatures to Classify Breast Cancer Subtypes.
Oztemur Islakoglu Y; Noyan S; Aydos A; Gur Dedeoglu B
OMICS; 2018 Nov; 22(11):709-716. PubMed ID: 30388053
[TBL] [Abstract][Full Text] [Related]
17. Circulating Pre-microRNA-488 in Peripheral Blood Is a Potential Biomarker for Predicting Recurrence in Breast Cancer.
Masuda T; Shinden Y; Noda M; Ueo H; Hu Q; Yoshikawa Y; Tsuruda Y; Kuroda Y; Ito S; Eguchi H; Ohno S; Mimori K
Anticancer Res; 2018 Aug; 38(8):4515-4523. PubMed ID: 30061217
[TBL] [Abstract][Full Text] [Related]
18. Identification of differentially expressed circulating serum microRNA for the diagnosis and prognosis of Indian non-small cell lung cancer patients.
Kumar S; Sharawat SK; Ali A; Gaur V; Malik PS; Kumar S; Mohan A; Guleria R
Curr Probl Cancer; 2020 Aug; 44(4):100540. PubMed ID: 32007320
[TBL] [Abstract][Full Text] [Related]
19. Clinical and
Ilkhani K; Delgir S; Safi A; Seif F; Samei A; Bastami M; Alivand MR
Anticancer Agents Med Chem; 2021; 21(7):927-935. PubMed ID: 32972352
[TBL] [Abstract][Full Text] [Related]
20. High-throughput screens identify microRNAs essential for HER2 positive breast cancer cell growth.
Leivonen SK; Sahlberg KK; Mäkelä R; Due EU; Kallioniemi O; Børresen-Dale AL; Perälä M
Mol Oncol; 2014 Feb; 8(1):93-104. PubMed ID: 24148764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]